GHRS
Price
$29.49
Change
+$1.30 (+4.61%)
Updated
Aug 14 closing price
Capitalization
2.02B
12 days until earnings call
Intraday BUY SELL Signals
NKTX
Price
$2.33
Change
+$0.03 (+1.30%)
Updated
Aug 14 closing price
Capitalization
166.89M
89 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GHRS vs NKTX

GHRS vs NKTX Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GHRS vs. NKTX commentary
Aug 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GHRS is a StrongBuy and NKTX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 15, 2026
Stock price -- (GHRS: $28.19 vs. NKTX: $2.30)
Brand notoriety: GHRS and NKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GHRS: 101% vs. NKTX: 50%
Market capitalization -- GHRS: $1.93B vs. NKTX: $164.38M
GHRS [@Biotechnology] is valued at $1.93B. NKTX’s [@Biotechnology] market capitalization is $164.38M. The market cap for tickers in the [@Biotechnology] industry ranges from $130.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GHRS’s FA Score shows that 0 FA rating(s) are green whileNKTX’s FA Score has 1 green FA rating(s).

  • GHRS’s FA Score: 0 green, 5 red.
  • NKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, GHRS is a better buy in the long-term than NKTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GHRS’s TA Score shows that 2 TA indicator(s) are bullish while NKTX’s TA Score has 4 bullish TA indicator(s).

  • GHRS’s TA Score: 2 bullish, 6 bearish.
  • NKTX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, NKTX is a better buy in the short-term than GHRS.

Price Growth

GHRS (@Biotechnology) experienced а -8.00% price change this week, while NKTX (@Biotechnology) price change was +0.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.59%. For the same industry, the average monthly price growth was -1.35%, and the average quarterly price growth was +2889.08%.

Reported Earning Dates

GHRS is expected to report earnings on Aug 26, 2026.

NKTX is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (+0.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GHRS($2.02B) has a higher market cap than NKTX($167M). GHRS YTD gains are higher at: 121.969 vs. NKTX (24.324). GHRS has higher annual earnings (EBITDA): -56.03M vs. NKTX (-107.08M). GHRS has more cash in the bank: 267M vs. NKTX (230M). GHRS has less debt than NKTX: GHRS (432K) vs NKTX (75M). GHRS (0) and NKTX (0) have equivalent revenues.
GHRSNKTXGHRS / NKTX
Capitalization2.02B167M1,211%
EBITDA-56.03M-107.08M52%
Gain YTD121.96924.324501%
P/E RatioN/AN/A-
Revenue00-
Total Cash267M230M116%
Total Debt432K75M1%
FUNDAMENTALS RATINGS
NKTX: Fundamental Ratings
NKTX
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
60
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
GHRSNKTX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
79%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 10 days ago
90%
Bullish Trend 8 days ago
84%
Declines
ODDS (%)
Bearish Trend 4 days ago
84%
Bearish Trend 17 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
GHRS
Daily Signal:
Gain/Loss:
NKTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
NMAR32.650.09
+0.28%
Innovator Growth-100 Pwr Buffr ETF - Mar
ENHI27.810.05
+0.17%
iShares Enhanced International Actv ETF
YEAR50.280.04
+0.08%
AB Ultra Short Income ETF
IMST7.23N/A
N/A
Bitwise MSTR Option Income Strategy ETF
NEBX34.69-1.05
-2.94%
Tradr 2X Long NBIS Daily ETF

GHRS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GHRS has been loosely correlated with ATAI. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if GHRS jumps, then ATAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GHRS
1D Price
Change %
GHRS100%
-6.78%
ATAI - GHRS
39%
Loosely correlated
+0.28%
RXRX - GHRS
36%
Loosely correlated
+0.61%
CRBU - GHRS
36%
Loosely correlated
-5.29%
ABSI - GHRS
35%
Loosely correlated
-0.42%
NKTX - GHRS
35%
Loosely correlated
-3.77%
More

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with EDIT. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
-3.77%
EDIT - NKTX
53%
Loosely correlated
-1.06%
RXRX - NKTX
49%
Loosely correlated
+0.61%
PRME - NKTX
48%
Loosely correlated
-0.94%
RCKT - NKTX
48%
Loosely correlated
-2.05%
VIR - NKTX
47%
Loosely correlated
+0.45%
More